← Eichor
Study identifier: NCT05562375 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Predictive Value of GOCCLES® Device for Early Diagnosis of Oral Potentially Malignant Disorders

Condition: Oral Potentially Malignant Disorders · Oral Cancer  ·  Sponsor: Universidad Rey Juan Carlos

PhaseNA
Planned participants73
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Oral potentially malignant disorders (OPMDs) are chronic pathologies which can suffer dysplastic alterations and evolve into oral cancer. The diagnosis of those pathologies is commonly done by visual inspection, which is not capable of determining the presence or not of dysplasia. Furthermore, this type of diagnosis depends greatly on the expertise and training of the professional. In recent years, new methods that can help early oral cancer diagnosis have been developed. A new device has been commercialized, named GOCCLES® (Glasses for Oral Cancer Curing Light Exposed Screening), based on the autofluorescence principle. The hypothesis of this study is that GOCCLES® device could be an effective tool to help in early detection of oral cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Rocío Teresa Martín Muñoz  ·  645468417  ·  rt.martin@alumnos.urjc.es

Always discuss trial participation with your own doctor first.

Locations (1)

Universidad Rey Juan Carlos de MadridAlcorcón, Madrid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05562375